How much is the difference between second-generation and third-generation IVF costs in Thailand? Real cost comparison analysis
Opening: Real consultation scenario
▎Real consultation scenario
A 34-year-old woman, married for 3 years without pregnancy. Her husband's semen analysis showed: sperm concentration 4.8 million/mL, motility 11%, normal morphology 1.5%, classified as severe oligoasthenoteratozoospermia. The woman's AMH was 1.8 ng/mL, and antral follicle count (AFC) was 8. She consulted through online channels, with the core question: "What is the actual cost difference between second-generation and third-generation IVF in Thailand? My husband's sperm is so poor, should we directly go for third-generation?"
This question involves three aspects: technology choice, cost budget, and medical indications. The following breaks down the cost differences, technical principles, hospital pricing, and decision-making logic.
How much is the cost difference between second-generation and third-generation IVF: Direct answer
In Thailand, the cost difference between second-generation IVF (ICSI) and third-generation IVF (PGT) is primarily driven by the embryo genetic screening step. Depending on the hospital, screening type, and number of embryos, the total cost difference is typically between 50,000–150,000 THB (approximately 10,000–30,000 RMB). Specific reference ranges are as follows:
- Total cost of second-generation IVF (ICSI): Approximately 80,000–150,000 THB (approx. 16,000–30,000 RMB)
- Total cost of third-generation IVF (PGT): Approximately 150,000–300,000 THB (approx. 30,000–60,000 RMB)
The core of the cost difference lies in the fact that third-generation IVF adds embryo biopsy, whole genome amplification, genetic analysis, and genetic counseling steps on top of second-generation. Additionally, embryos for third-generation IVF must be cultured to the blastocyst stage (day 5–6), increasing laboratory culture time and consumable costs.
Module B: Why the cost differenceRoot cause of cost difference: Technical process breakdown
To understand the cost difference, one must first see the technical process differences between second-generation and third-generation IVF.
Technical steps of second-generation IVF (ICSI)
- Ovarian stimulation and egg retrieval — same as conventional IVF
- Intracytoplasmic sperm injection (ICSI) — laboratory staff select morphologically normal sperm and inject directly into the oocyte
- Embryo culture — generally cultured to day 3 (cleavage stage) or day 5 (blastocyst)
- Embryo transfer — select 1–2 embryos for transfer, remaining embryos cryopreserved
The core cost of ICSI lies in the micromanipulation equipment and the embryologist's technical time. Laboratory hardware requirements are high, but compared to third-generation, there is no genetic screening step.
Additional steps of third-generation IVF (PGT)
- Blastocyst culture — must be cultured to day 5–6 blastocyst stage for biopsy
- Embryo biopsy — remove 3–5 cells from the trophectoderm of the blastocyst, requiring extremely high technical skill
- Whole genome amplification — amplify DNA from trace cells to analyzable quantity
- Genetic analysis — perform chromosome or gene testing based on screening purpose (PGT-A / PGT-M / PGT-SR)
- Genetic counseling — geneticist interprets the report and assesses whether the embryo is transferable
Among these, embryo biopsy and genetic analysis are the two most expensive steps. PGT-M (monogenic disease screening) also requires custom family-specific probes, costing even more, typically an additional 50,000–100,000 THB.
6 core factors affecting cost
Even for the same second-generation or third-generation IVF, final costs can vary significantly between different hospitals and protocols. The following factors directly influence total expenditure:
| Factor | Specific explanation |
|---|---|
| Hospital positioning and brand | International general hospitals (e.g., Bumrungrad) charge higher fees, while specialized reproductive centers (e.g., Jetanin) are relatively moderate, with price differences up to 30%–50%. |
| Screening technology type | PGT-A is the least expensive, PGT-SR is moderate, and PGT-M is the highest (requires custom probes). Some hospitals charge on a sliding scale based on the number of embryos. |
| Number of biopsied embryos | Most hospitals charge per biopsied embryo, approximately 10,000–15,000 THB per embryo. The more embryos biopsied, the higher the total screening cost. |
| Medication cost differences | Ovarian stimulation drug brand (imported vs. domestic), dosage, and duration vary per individual, costing approximately 20,000–60,000 THB. |
| Embryo freezing and storage | The initial freezing fee is usually included in the package, but subsequent annual storage fees must be paid separately, approximately 10,000–20,000 THB per year. |
| Additional services | Translation, accommodation, transportation, nutritional counseling, and other non-medical costs depend on individual needs and are usually not included in the medical quote. |
When consulting, it is recommended to ask the hospital for a detailed cost breakdown, clearly indicating which items are included in the package and which require additional payment. Avoid looking only at the total price and ignoring hidden costs.
Module F: Differences between hospitalsCost reference for major IVF hospitals in Thailand
The following data are reference ranges for 2023–2024. Actual costs are subject to each hospital's latest quotation. All cost units are in 10,000 THB.
| Hospital name | Second-generation IVF (ICSI) | Third-generation IVF (PGT) | Difference range |
|---|---|---|---|
| Jetanin | 10–13 | 18–22 | 5–9 |
| BNH Hospital | 12–15 | 22–26 | 7–11 |
| VitalLife | 9–12 | 16–20 | 5–8 |
| Bumrungrad International | 12–15 | 22–28 | 8–13 |
It should be noted that the above third-generation IVF costs default to include PGT-A (chromosomal aneuploidy screening). If PGT-M (monogenic disease screening) is required, the cost will be higher, with additional probe customization and genetic counseling fees.
Module C: Doctor's perspectiveDoctor's decision logic: When to choose second-generation, when to choose third-generation
From a reproductive medicine perspective, choosing between second-generation and third-generation depends primarily on medical indications, not cost or "newer technology is better."
Cases suitable for second-generation IVF (ICSI)
- Male factor infertility: Severe oligospermia, asthenospermia, teratozoospermia, or obstructive azoospermia (sperm can be retrieved via aspiration).
- Previous IVF fertilization failure: Low or complete failure of fertilization with conventional IVF.
- Use of frozen eggs or sperm: Reduced viability of thawed sperm or eggs, requiring ICSI to improve fertilization rate.
- Both partners have normal chromosomes, no family history of genetic diseases, and the woman is ≤ 35 years old with no history of recurrent miscarriage.
Cases suitable for considering third-generation IVF (PGT)
- Advanced maternal age (≥ 38 years): Significantly increased risk of embryonic chromosomal aneuploidy.
- Recurrent spontaneous miscarriage (≥ 2 times): May be caused by embryonic chromosomal abnormalities.
- Chromosomal structural abnormality in one partner: Such as balanced translocation, Robertsonian translocation, inversion, etc.
- Carrier of monogenic disease: Such as thalassemia, spinal muscular atrophy (SMA), hereditary deafness, etc.
- Previous IVF repeated implantation failure: After excluding endometrial and other factors, consider embryonic chromosomal factors.
4 common pitfalls in cost and technology selection
During actual consultations and visits, the following misconceptions frequently arise and require special attention:
Myth 1: Believing third-generation IVF success rate is definitely higher than second-generation
The goal of third-generation IVF is "screening" rather than "improving implantation rate." For chromosomally normal embryos, there is no significant difference in implantation rates after transfer between second-generation and third-generation. The advantage of third-generation lies in reducing miscarriage rates and birth defect risks, not in enabling embryos that cannot implant to do so.
Myth 2: Ignoring the potential loss from embryo biopsy
Biopsy can damage embryos. Some embryos may not pass genetic analysis after biopsy, or may not be freezable due to reduced viability after biopsy. This means that embryos originally available for transfer may become fewer or even non-existent after third-generation screening. This is particularly concerning for individuals with low follicle counts or average embryo quality.
Myth 3: Only looking at the "package price," ignoring hidden costs
Some hospitals' quotes only include basic medical and laboratory fees, excluding medication costs, embryo freezing fees, storage fees, genetic counseling fees, PGT probe fees, etc. Before signing, be sure to confirm the scope of included costs and request a written breakdown.
Myth 4: Blindly pursuing "third-generation" while ignoring personal conditions
Without any genetic indications, choosing third-generation solely because "I want third-generation" may lead to increased embryo loss, higher costs, but limited clinical benefit. Medical decisions should be based on objective test results and doctor evaluation, not technology preference.
Module G: Easily overlooked details4 easily overlooked details beyond cost
- Screening accuracy is not 100%: PGT-A accuracy is about 95%–98%, with the possibility of false positives and false negatives. Prenatal diagnosis (e.g., amniocentesis) is still needed before transfer for confirmation.
- Embryo mosaicism issue: Some embryos are mosaic (containing both normal and abnormal cells). Genetic counselors will assess the mosaic ratio and transfer risk, but the decision is more complex.
- Long-term storage cost of frozen embryos: Annual storage fees are required, and some hospitals require a lump-sum payment for several years, which should be included in the overall budget.
- Time cost difference: Third-generation IVF requires waiting for genetic analysis results (about 2–4 weeks), making the frozen embryo transfer cycle longer, and the overall treatment cycle is 1–2 months longer than second-generation.
Summary of frequently asked questions
Q1: Which has a higher success rate, second-generation or third-generation IVF?
A: For chromosomally normal embryos, there is no significant difference in live birth rates after transfer between second-generation and third-generation. The advantage of third-generation is in reducing miscarriage rates and birth defect risks due to chromosomal abnormalities, not in improving single-transfer success rates. For older women or those with recurrent miscarriage, third-generation may improve cumulative live birth rates.
Q2: In Thailand, what is the cost difference between PGT-A and PGT-M for third-generation IVF?
A: PGT-A is usually included in the third-generation IVF package, calculated per embryo, approximately 10,000–15,000 THB each. PGT-M requires custom probes, costing about 50,000–100,000 THB, plus screening fees per embryo, making the total cost 60,000–120,000 THB higher than PGT-A.
Q3: Does embryo biopsy harm the embryo?
A: Current data indicate that when performed by an experienced embryologist, the damage rate to blastocysts from biopsy is very low (< 2%). However, embryos need to be frozen after biopsy, and the freeze-thaw process causes about 5%–10% embryo loss. For individuals with few embryos or average quality, the benefits and risks of biopsy need to be evaluated.
Q4: The man has oligoasthenospermia, the woman's AMH is normal. Can we directly do third-generation?
A: If only male factors are present, the woman is ≤ 35 years old, and there is no family history of genetic diseases, second-generation IVF (ICSI) is usually sufficient. Adding third-generation screening does not improve fertilization or implantation rates, but increases cost and embryo loss. It is recommended to try ICSI first, and consider PGT only if repeated implantation failure or miscarriage occurs.
Q5: Does the cost of IVF in Thailand include medication fees?
A: Most hospitals' "package price" does not include ovarian stimulation medication costs, or only includes some basic medications. Medication costs are calculated individually based on ovarian response and treatment protocol, generally between 20,000–60,000 THB. Be sure to confirm whether medication costs are included before signing.
Preimplantation genetic testing (PGT) is an auxiliary technology and cannot fully replace prenatal diagnosis. Even after transferring a PGT-screened normal embryo, residual risks remain, including missed mosaicism, new mutations in monogenic diseases, etc. All PGT pregnancies are recommended to undergo prenatal diagnosis (such as CVS or amniocentesis) after pregnancy. Additionally, cost is only one dimension of technology choice; the core is evaluation based on individual medical indications. It is recommended to develop an individualized plan under the guidance of a reproductive doctor and genetic counselor.
This information is compiled based on general knowledge in the assisted reproduction industry and public data from major reproductive centers in Thailand. Fee standards may change with hospital policies, exchange rates, and medical technology updates. Please refer to real-time consultations. This does not constitute medical advice; specific treatment plans should be discussed with a licensed physician in person.
